Alesi Surgical’s Ultravision2 Demonstrates Its Value in Robotic Surgery

IW Capital portfolio company, Alesi Surgical, has seen its Ultravision2 technology demonstrate its value in the robotic operating theatre, supporting a recent robotic hiatal hernia repair at San Giovanni Addolorata Hospital in Rome.

Robotic surgery continues to play a growing role in modern healthcare, offering surgeons greater precision and control. However, robotic procedures deliver their best results when the supporting technology around them enhances control, visibility and stability throughout the operation.

Surgical smoke is one of the challenges that can affect this. Smoke produced during surgery can obscure a surgeon’s view and lead to pauses in a procedure. Alesi Surgical’s Ultravision2 addresses this by clearing surgical smoke, helping surgeons see clearly and work with fewer interruptions.

The technology was recently used in a robotic hiatal hernia repair performed by Prof. Emanuele Santoro, Director of General and Oncologic Surgery at San Giovanni Addolorata Hospital. The result was a clear surgical field, low CO₂ consumption and stable pressure throughout the procedure, with minimal intervention required from the anaesthesia team.

These outcomes highlight the practical benefits Ultravision2 can bring to robotic surgery. A clearer field supports surgical precision, while stable conditions and reduced intervention help procedures run more smoothly. Lower CO₂ consumption also points to the potential for more efficient and cost-effective surgery.

As hospitals look to maximise the value of their investment in robotic surgery, technologies that improve efficiency and support better operating conditions are becoming increasingly important. Ultravision2’s performance in this procedure shows how Alesi Surgical’s technology can complement robotic systems and help surgical teams get the most from them.

At IW Capital, we continue to support innovative UK businesses developing technology that improves outcomes for patients and healthcare professionals. It is great to see smarter, more cost-effective robotic surgery in action, and we look forward to seeing Ultravision2 make a difference in even more operating theatres.